In a groundbreaking achievement, NASA's Perseverance rover has detected auroras on Mars for the first time, thanks to a solar flare and coronal mass ejection. This discovery opens up new frontiers for future Martian exploration and research.
A stunning new Archaeopteryx fossil reveals specialized wing feathers crucial for flight, giving scientists fresh insights into how the first birds took to the skies 150 million years ago.
In a groundbreaking first stop of his international tour, Trump leads a delegation of CEOs to Saudi Arabia, striking $600 billion in AI chip deals that could reshape the Middle East's tech landscape and strengthen U.S.-Saudi ties.
As some Afrikaners accept Trump's refugee offer, many insist they are not fleeing persecution but rather remain committed to their homeland. Explore the complexities behind this controversial topic.
A fierce battle is brewing among House Republicans over the state and local tax (SALT) deduction, threatening to derail President Trump’s agenda. With factions at odds, can they find common ground before it's too late?
As peace talks between Russia and Ukraine approach, the absence of Trump and Putin raises questions about potential breakthroughs. With high stakes and a call for ceasefire, will this lead to a resolution or further complications?
In a surprising announcement, Jaguar Land Rover has confirmed it has no intentions of building cars in the US, citing President Trump's tariffs as a significant factor. This comes after a pause in shipments and growing concerns across the motor industry about the unpredictable trade landscape.
Overdose deaths in the U.S. fell by nearly 30,000 last year, marking a significant decline in the drug crisis. Experts are cautiously optimistic about the progress, attributing it to improved treatment access and changes in the drug supply.
China's equity markets remain volatile despite a tariff reprieve. Meanwhile, Australia sees a surge in employment, and the Chinese central bank relaxes reserve requirements to boost liquidity amidst trade tensions.
After a steep 18% drop, UnitedHealth Group's shares saw a modest rebound as analysts maintain positive ratings despite the company withdrawing its guidance and the CEO's resignation. Will the stock recover?
